Refine
Document Type
- Article (7)
Language
- English (7)
Has Fulltext
- yes (7)
Is part of the Bibliography
- no (7)
Keywords
- AML (3)
- Acute myeloid leukemia (3)
- Chemotherapy (2)
- Induction chemotherapy (2)
- Survival (2)
- Antibiotic steward-ship (1)
- Antibiotics (1)
- Bone marrow (1)
- Bone marrow aspiration (1)
- CBC (1)
- CDI (1)
- Cancer chemotherapy (1)
- Cytogenetics (1)
- Death rates (1)
- Deletion mutation (1)
- ESBL (1)
- Enterobacteriaceae (1)
- Fevers (1)
- Fluid overload (1)
- Hepatocellular carcinoma (1)
- Hospitals (1)
- Infection (1)
- Intensive care treatment (1)
- Karyotypes (1)
- Liver cancer (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Multidrug-resistant organisms (1)
- Neutropenia (1)
- Peripheral blood smears (1)
- Relapse surveillance (1)
- VRE (1)
- Vacuoles (1)
- bleeding (1)
- induction chemotherapy (1)
- intracranial hemorrhage (1)
- platelet substitution (1)
Institute
- Medizin (7)
Introduction: MDRO-colonization has been shown to impair survival in patients with hematological malignancies and solid tumors as well as in patients with liver disease. Despite the increasing spread of multidrug-resistant organisms (MDRO), its impact on patients with hepatocellular carcinoma (HCC) has not been studied. We conducted this retrospective study to analyze the impact of MDRO-colonization on overall prognosis in HCC patients.
Materials and methods: All patients with confirmed HCC diagnosed between January 2008 and December 2017 at the University Hospital Frankfurt were included in this study. HCC patients with a positive MDRO screening before or within the first 90 days after diagnosis of HCC were defined as colonized HCC patients, HCC patients with a negative MDRO screening were defined as noncolonized HCC patients.
Results: 59 (6%) colonized and 895 (94%) noncolonized HCC patients were included. Enterobacterales with extended-spectrum β-lactamase-like phenotype with or without resistance to fluoroquinolones (ESBL/ ± FQ) were the most frequently found MDRO with 59%, followed by vancomycin-resistant Enterococcus faecium with 37%. Colonized HCC patients had more severe cirrhosis and more advanced HCC stage compared to noncolonized HCC patients. Colonized HCC patients showed an impaired survival with a median OS of 189 days (6.3 months) compared to a median OS of 1001 days (33.4 months) in noncolonized HCC patients. MDRO-colonization was identified as an independent risk factor associated with survival in multivariate analysis.
Conclusion: MDRO-colonization is an independent risk factor for survival in patients with HCC highlighting the importance of regular MDRO screening, isolation measures as well as interdisciplinary antibiotic steward-ship programs to guide responsible use of antibiotic agents.